Company
Technology
Team
Board of Directors
Management
Extended Management
Partners & Advisors
Preclinical Research
Clinical Research
Strategic Investment
Investors
News
Contact
News
Finanz und Wirtschaft: Doubts about the market for corona boosters
24 June 2022
READ MORE
RocketVax SARS-CoV-2 Vaccine (RVX-sCPD9) Significantly Outperforms mRNA and Adenovirus Vector-Based Technologies in Animal Models
9 June 2022
READ MORE
RocketVax strengthens its technology portfolio and Covid-19 vaccine development through broad-based partnerships
16 March 2022
READ MORE
Dr. Vladimir Cmiljanovic is the recipient of the 2021 Nikola Tesla Award for the achievements in the field of science
12 November 2021
READ MORE
RocketVax successfully raises CHF 7.2 million of seed funding
3 August 2021
READ MORE
Batavia Biosciences to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
6 July 2021
READ MORE
Basel government approves one million for research to develop novel vaccine against SARS-CoV-2 coronavirus
17 June 2021
READ MORE
RocketVax AG and Swiss Rockets AG expand science and leadership teams
3 June 2021
READ MORE
Innosuisse supports the Basel biotech company RocketVax in its research into the second generation of SARS-CoV-2 vaccines
16 April 2021
READ MORE
Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
10 November 2020
READ MORE